Mature T cells recognize and respond to the antigen/MHC complex through their antigen-specific receptors (TCR). The most immediate consequence of TCR activation is the initiation of signaling pathways including induction of specific protein tyrosine kinases (PTKs), breakdown of phosphatidylinositol 4,5-biophosphate (PIP2), activation of protein kinase C (PKC) and elevation of intracellular calcium ion concentration. These early events are transmitted to the nucleus and result in
clonal expansion of T cells,
upregulation of activation markers on the cell surface,
differentiation into effector cells,
induction of cytotoxicity or cytokine secretion, and
induction of apoptosis.
One of the most common ways to assess T cell activation is to measure T cell proliferation upon in vitro stimulation of T cells via antigen or agonistic antibodies to TCR.
This protocol is written as a starting point for examining in vitro proliferation of mouse splenic T-cells and human peripheral T cells stimulated via CD3. All steps where optimization by the user can be achieved for meaningful results have been highlighted. Briefly, these include titration of the cell concentration used, titration of the activating reagents and the optimal culture period for the best activation response.
1X sterile PBS
Anti-mouse CD3e, 145-2C11:
Supplemented RPMI-1640 <click here> for recipe
Sterile single-cell suspension of mouse spleen or lymph nodes
96-well flat-bottom microtiter plates with lids (Costar Cat. No. 3596)
MTT Buffer <click here> for recipe
MTT Lysing Solution <click here> for recipe
Concanavalin A, optional (ConA, Sigma Cat. No. C5275)
Pipettes and pipettors, Multichannel pipettor
Centrifuge
37°C, CO2 incubator
96-well micro test spectrophotometer
20 minutes antibody preparation for coating wells
20 minutes preparation of spleen single cell suspension
20 minutes to set up the assay
2-4 days incubation
Prepare a 5-10 µg/ml solution of anti-CD3e (145-2C11) in sterile PBS. Calculate the number of wells required for each experimental condition and consider triplicate samples for each condition. For example, to coat one-half plate (48 wells) 2.6 ml of antibody solution is required.
Note: We have performed titration studies and found these concentrations of 145-2C11 to induce a maximal response. However, a pilot experiment to determine efficacy of other concentrations of this antibody to induce cellular activation can be performed. For co-stimulation studies using antibodies to other antigens, a suboptimal activation with anti-CD3 may be required. To achieve suboptimal activation via anti-CD3, a 0.5-0.1 µg/ml 145-2C11 antibody solution can be used.
Dispense 50 µl of the antibody solution in each well of the 96-well assay plate. For the control unstimulated wells, add 50 µl of sterile PBS.
Tightly cover the plate with Parafilm to avoid sample evaporation and incubate at 37°C for 2 hours or alternatively prepare the plate one day in advance and keep at 4°C overnight.
Just before adding cells, remove the 50 µl antibody solution with a multichannel pipettor.
Rinse each well with 200 µl of sterile PBS and discard PBS.
Repeat step 5 to remove all unbound antibody from each well.
Harvest spleen and prepare a single cell suspension under sterile condition. Follow the red cell lysis protocol to remove red cells. <click here> for RBC lysis protocol.
Count cells and resuspend in complete RPMI-1640 at 106/ml.
Note: This concentration of spleen cells gives a good response. If experimental conditions require, a titration of cell concentrations (2-3 x 106/ml to 105/ml) should be performed for optimization.
After washing the wells with PBS (step 6 above), add 200 µl of the cell suspension to each well and place in a humidified 37°C, 5% CO2 incubator.
Note: For an additional stimulation control, incubate cells in 3 wells with Concanavalin A at 1-4 µg ConA per ml of culture medium.
Incubate for 2-4 days.
Note: Proliferation of cells between days 2 and 4 gives a good signal; however, this incubation time can also be optimized for specific experimental conditions.
Add 20 µl of the MTT buffer to each well and put back in the incubator for 4 hours.
Add 50 µl of the MTT Lysis Solution to each well, vortex gently and incubate overnight
Read the plate at 570 nm the next day.
Calculate the mean and standard errors and graph the data.
Human PBMCs can be activated in vitro by soluble anti-human CD3 antibodies. We have performed titration studies with these antibodies and established the following protocol for stimulation of PBMC.
1X sterile PBS
Anti-human CD3:
Supplemented RPMI-1640 <click here> for recipe
Sterile PBMC
96-well flat-bottom microtiter plates with lids (Costar Cat. No. 3596)
MTT Buffer <click here> for recipe
MTT Lysing Solution <click here> for recipe
Pipettes and pipettors, Multichannel pipettor
Centrifuge
37°C, CO2 incubator
96-well micro test spectrophotometer
30 minutes preparation of PBMC
20 minutes to set up the assay
2-4 days incubation
Prepare PBMC and resuspend the cells at 1-2 x 106/ml of supplemented RPMI.
Note: This concentration of PBMC gives a good response. If experimental conditions require, a titration of cell concentrations (2-3 x 106/ml to 105/ml) should be performed for optimization.
Add 100 µl of the cell suspension to each well. For each condition, use triplicate wells.
Add soluble antibody in 100 µl to each well. Titrate antibodies for optimal performance in the assay conditions used. If isolated T cells are to be used in proliferation assays, we recommend using these antibodies at 10 µg/ml immobilized on plastic (i.e. bound to wells of 96-well assay plates).
Place in a humidified 37°C, 5% CO2 incubator.
Incubate for 2-4 days.
Note: Proliferation of cells between day 2 and 4 gives a good signal; however, this incubation time can also be optimized for specific experimental conditions.
Add 20 µl of the MTT buffer to each well and put back in the incubator for 4 hours.
Add 50 µl of the MTT Lysis Solution to each well, vortex gently and incubate overnight.
Read the plate at 570 nm the next day.
Calculate the mean and standard errors and graph the data.
900 ml RPMI-1640 (Hyclone Cat. No. SH30027.02)
100 ml FBS (Hyclone Cat. No. SH30151.03) Heat inactivated (10% final)
1 ml 2-mercaptoethanol (GibcoBRL Cat. No. 21985-023)
10 ml L-Glutamine (Hyclone Cat. No. SH30034.01)
Antibiotic cocktail (optional)
MTT (Sigma Cat. No. M5655) make a 5 mg/ml stock solution in 1X PBS - Keep protected from light.
20% SDS 50% DMF
文|《中国科学报》记者李思辉实习生何睿她是一位知名三甲医院的科室主任:不仅负责科室的管理工作,而且每周4个半天坐诊,每年主刀800多台手术;她是院士师门的“大师姐”:繁忙的临床工作之余,做研究、带学生......
Fanzor(Fz)是一种广泛存在于真核生物结构域的ωRNA引导内切酶,具有独特的基因编辑潜力。2024年8月28日,麻省理工学院/博德研究所张锋团队在Cell在线发表题为“Structuralins......
叶绿体蛋白在ATP酶马达的驱动下,通过叶绿体外膜(TOC)转座子和叶绿体内膜(TIC)超复合体的转座子导入。Ycf2-FtsHi复合体已被确定为叶绿体进口马达。然而,其在前蛋白转运过程中与TIC复合物......
文| 《中国科学报》记者李思辉实习生毕若雪“2021年暑假的一个凌晨,我突然灵机一动,思考了很久的一个模型突然清晰起来。我立即从床上蹦起来,花了5分钟,在纸上把它清楚地画了出来!”说起最近发......
“一稿多投”一直被认为是不端的行为,但这个“规矩”是在纸质时代信息沟通不畅的情况下制定的,近年来广大作者呼吁取消这一观念的声音已振聋发聩!让人欣喜的是,截止目前,已经有两大国际知名出版社响应了这一呼吁......
2024年4月23日,北京理工大学生命学院肖振宇副教授、中国科学院动物研究所王红梅、于乐谦、郭靖涛研究员、中国农业大学魏育蕾教授、郑州大学第一附属医院何南南助理研究员在国际学术期刊Cell发表文章《3......
2019年10月3日,加州大学圣地亚哥分校BrendaL.Bloodgood团队(G.StefanoBrigidi为第一作者)在Cell在线发表题为“GenomicDecodingofNeuronal......
美国宾夕法尼亚大学佩雷尔曼医学院科研人员发现,蚂蚁的血脑屏障在控制其行为方面起着积极的作用。血脑屏障可以调节蚂蚁大脑中的激素水平,从而影响他们在蚁群中的行为。相关研究成果发表在《Cell》杂志上。研究......
RNA引导系统利用引导RNA和靶核酸序列之间的互补性来识别遗传元件,在原核生物和真核生物的生物过程中都起着核心作用。例如,原核CRISPR-Cas系统为细菌和古细菌提供了对外来遗传因子的适应性免疫。C......
大约700万年前,人类从我们最接近的动物亲戚黑猩猩那里分离出来,在进化树上形成了我们自己的分支。在此后的时间里---从进化的角度看是短暂的---我们的祖先进化出了使我们成为人类的性状,包括比黑猩猩大得......